Clinical Implications of SPRINT

Most of the editorials and commentaries about the SPRINT trial have given it a positive spin and recommended that target BPs should be lower as a result of this trial. These commentaries have ignored the finding that individuals experiencing at least one serious adverse event were numerically increased in the low BP target group.

[98] Does SPRINT change our approach to blood pressure targets? | Therapeutics Initiative
Ronald H Estey, www.ti.ubc.ca

Like what you read? Give Ray Collins a round of applause.

From a quick cheer to a standing ovation, clap to show how much you enjoyed this story.